Redmile Group, LLC 89bio, Inc. Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,545,208 shares of ETNB stock, worth $14 Million. This represents 1.85% of its overall portfolio holdings.
Number of Shares
1,545,208
Previous 1,886,444
18.09%
Holding current value
$14 Million
Previous $13.7 Million
10.64%
% of portfolio
1.85%
Previous 1.44%
Shares
9 transactions
Others Institutions Holding ETNB
# of Institutions
212Shares Held
162MCall Options Held
289KPut Options Held
1.6M-
Janus Henderson Group PLC London, X020.8MShares$188 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$180 Million4.27% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.2MShares$128 Million4.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.5MShares$85.9 Million3.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.24MShares$74.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $420M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...